SOMAÍ Pharmaceuticals

SOMAÍ Pharmaceuticals Somai is fast becoming one of the most recognized and well-developed pharmaceutical brands in the EU.

A leading EU-GMP European vertically integrated Multi-Country Operator (MCO) company with a global footprint of distribution for the largest and most advanced EU GMP-certified cannabinoid-containing pharmaceutical extract portfolio Somai Pharmaceuticals LTD is a European pharmaceutical and biotech company centered on manufacturing in Lisbon, Portugal and distribution of EU GMP-certified cannabinoi

d-containing pharmaceuticals throughout the European Union and globally. Somai emphasizes scientific pharmacology applications with EU-GMP standards to deliver treatments to the endocannabinoid system, effectively and with consistency across all markets. Somai's product development knowledge was honed in the competitive American market, and is the largest and most advanced cannabinoid manufacturing facility across legal European markets producing medicines products and registered API's. Somai has brought together an all-star team of scientists and KOL's from around the world with various clinical experiences to guide Somai's product development and acceptance globally. Somai stresses education and continual R&D, which started from the USA as transformative developments, to help EU doctors and patients properly diagnose and treat the individual indications by providing variable dosage choices. Somai’s primary goal is producing the most advanced products with the most innovative delivery methods to create maximum bioavailability and healing for patients. As a global biotech player concentrating on cannabinoids, Somai has a unique pipeline of current and future products that will be on the market starting in late 2022. They already boast one of the largest IP (Intellectual Property) vaults of APIs that weren’t accessible to Europe until recently. Somai’s near term products conform to the highest standards of herbal medicine (ACM) and specialized cannabinoid API’s for R&D, but also keeps a steady eye on the horizon of future clinical trials for their proprietary pipeline, setting it up to be well positioned for the next decade.

17/06/2026

Inside SOMAÍ Cultivation with Dr. Nigel Gale 🌱

In this episode, we follow the cuttings as they move from the vegetative phase into flowering — a key stage where light, nutrition, root health, and canopy uniformity all play an important role.

From strong vegetative growth to healthy roots and a well-balanced canopy, every step is managed with consistency and care to support the development of high-quality medical cannabis flower.

Stay tuned as we continue following this cycle.

15/06/2026

🔵 Throwing it back to Cannabis Europa 2026 🇬🇧

Thank you to everyone who took the time to meet with the SOMAÍ team, exchange ideas, and discuss the future of medical cannabis.

Events like Cannabis Europa continue to demonstrate the momentum behind the industry and the importance of collaboration across cultivation, manufacturing, distribution, healthcare, and innovation.

It was a pleasure reconnecting with partners, meeting new faces, and sharing how SOMAÍ continues to expand access to regulated cannabinoid-based medicines around the world.

💙 Thank you for a great event. We’re already looking forward to seeing everyone again next year.

🔵 SOMAÍ at the IgniteIt Chicago Cannabis Conference 2026 🇺🇸On June 16, Michael Sassano, Founder and Interim CEO of SOMAÍ...
08/06/2026

🔵 SOMAÍ at the IgniteIt Chicago Cannabis Conference 2026 🇺🇸

On June 16, Michael Sassano, Founder and Interim CEO of SOMAÍ, will join an exclusive IgniteIt panel discussion:

🎤 Beyond the Obvious: What’s Next in Global Cannabis?

As the global cannabis industry continues to evolve, the conversation is shifting beyond traditional markets and familiar opportunities. This panel will explore emerging regions, changing market dynamics, and the trends shaping the next phase of international cannabis growth.

🌐 Is Europe still the center of the global cannabis conversation?
🌐 Which markets are attracting the attention of industry leaders?
🌐 What signals should businesses be watching as the industry matures?

Join Michael and fellow industry experts as they discuss the future of global cannabis and the opportunities that lie ahead.

🌈 This Pride Month, SOMAÍ celebrates diversity, inclusion, and the value of creating environments where everyone feels r...
08/06/2026

🌈 This Pride Month, SOMAÍ celebrates diversity, inclusion, and the value of creating environments where everyone feels respected, supported, and empowered to be themselves.

Innovation thrives when different perspectives come together. As a global company, we are proud to work alongside colleagues, partners, healthcare professionals, and patients from diverse backgrounds, experiences, and communities around the world.

At SOMAÍ, we believe that respect, dignity, and equal opportunity should be part of every workplace, every partnership, and every patient journey.

Happy Pride Month from the SOMAÍ team. 💙

🔵 SOMAÍ at Mary Jane Berlin 2026 🇩🇪The countdown is on! The SOMAÍ team will be attending Mary Jane Berlin, taking place ...
05/06/2026

🔵 SOMAÍ at Mary Jane Berlin 2026 🇩🇪

The countdown is on! The SOMAÍ team will be attending Mary Jane Berlin, taking place June 11–14, 2026, one of Europe’s largest cannabis events, and we look forward to connecting with partners, healthcare professionals, pharmacies, and industry stakeholders from across the globe.

This year, SOMAÍ will be sharing a booth with Grastheke Apotheke, while also showcasing our collaboration with airobrands official, bringing together advanced inhalation technologies and EU-GMP cannabinoid formulations.

🔷 Explore SOMAÍ’s expanding portfolio of cannabinoid-based medicines
🔷 Learn more about the latest developments from Airo
🔷 Meet the team and discuss opportunities across Europe and beyond

Whether you're interested in extracts, inhalation products, international brand partnerships, or future collaborations, we'd love to connect.

📍 Visit us at Mary Jane Berlin, June 11–14, 2026, and discover what's next for SOMAÍ

📩 Want to schedule a meeting in advance? Contact us at: [email protected]

03/06/2026

Consistency starts at the cutting stage. 🔹

In this episode, Dr. Nigel Gale takes us inside the propagation stage at NovaSoma, SOMAÍ’s cultivation facility, showing how careful handling, clean practices, and controlled conditions help support healthy plant development from the very beginning.

Because in medical cannabis cultivation, every detail matters.

CannabisScience

03/06/2026

Consistency starts at the cutting stage. 🔹

In this episode, Dr. Nigel Gale takes us inside the propagation stage at NovaSoma, SOMAÍ’s cultivation facility, showing how careful handling, clean practices, and controlled conditions help support healthy plant development from the very beginning.

Because in medical cannabis cultivation, every detail matters.

SOMAÍ today announced the signing of an exclusive partnership agreement with IPS Pharma and Integro Medical Clinics to i...
27/05/2026

SOMAÍ today announced the signing of an exclusive partnership agreement with IPS Pharma and Integro Medical Clinics to introduce a portfolio of internationally recognized cannabis brands into the United Kingdom medical cannabis market.

The agreement covers the future launch of three globally recognized cannabis brands into the UK medical market in the coming months, representing a significant expansion of differentiated cannabinoid product offerings available to UK healthcare professionals and patients.

“The UK market is continuing to mature rapidly, and new patient demographics are increasingly looking for differentiated products backed by advanced pharmaceutical-grade producers,” said Michael Sassano, Founder and Interim CEO of SOMAÍ. “This partnership creates a strong foundation for introducing some of the industry’s most recognized international brands with unique genetic portfolios into the UK medical market.”

“At IPS Pharma and Integro Clinics, our focus has always been on improving patient access to safe, compliant, and high-quality cannabinoid medicines,” said Ashok Patel, Founder and Chairman of IPS Pharma. “Working together with SOMAÍ allows us to support the introduction of globally recognized brands through a structured and patient-focused approach.”

Read the full news here: https://www.einpresswire.com/article/915255345/soma-signs-exclusive-uk-agreement-to-launch-globally-recognized-cannabis-brands

🔵 SOMAÍ at CannaTrade 2026 🇨🇭The SOMAÍ team will be attending CannaTrade 2026 in Zurich from May 29–31, connecting with ...
25/05/2026

🔵 SOMAÍ at CannaTrade 2026 🇨🇭

The SOMAÍ team will be attending CannaTrade 2026 in Zurich from May 29–31, connecting with healthcare professionals, distributors, pharmacies, and industry partners across the Swiss market.

Rachel Wilson-Cannon, Commercial Director at SOMAÍ, will be on-site and available to discuss SOMAÍ’s expanding portfolio of EU-GMP cannabinoid-based medicines, including extracts, upcoming products, and differentiated international brands.

Interested in learning more about SOMAÍ’s product offerings and opportunities in Switzerland?
Reach out to schedule a meeting: [email protected]

🔵 Thailand’s cannabis industry is entering a new phase 🌏In his latest article for CannaReporter, Michael Sassano explore...
22/05/2026

🔵 Thailand’s cannabis industry is entering a new phase 🌏

In his latest article for CannaReporter, Michael Sassano explores the rapid evolution of the Thai cannabis market — from explosive cultivation growth and pricing pressure to the increasing importance of pharmaceutical standards and international market access.

As global demand for compliant cannabis products continues to rise, Thailand is quickly becoming one of the most closely watched regions in the industry.

🔷 The article explores:
• The expansion of Thailand’s indoor cultivation sector
• The challenges of meeting global pharmaceutical standards
• Pricing pressure and oversupply dynamics
• The growing role of EU-GMP pathways in international distribution

Read the full article here: https://cannareporter.eu/en/2026/04/30/canabis-na-tailandia-em-2026-de-suave-a-selvagem/

Address

Brisbane, QLD

Website

Alerts

Be the first to know and let us send you an email when SOMAÍ Pharmaceuticals posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to SOMAÍ Pharmaceuticals:

Shortcuts

Featured

Share

Category